Electrophysiologic characteristics and pharmacologic response of human cardiomyocytes isolated from a patient with hypertrophic cardiomyopathy.
about
The role of late I Na in development of cardiac arrhythmiasCalmodulin kinase II inhibitor regulates calcium homeostasis changes caused by acute β-adrenergic receptor agonist stimulation in mouse ventricular myocytes.Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.Divergent effect of adrenaline in human induced pluripotent stem cell derived cardiomyocytes obtained from hypertrophic cardiomyopathy.Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy.Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient.
P2860
Electrophysiologic characteristics and pharmacologic response of human cardiomyocytes isolated from a patient with hypertrophic cardiomyopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Electrophysiologic characteris ...... h hypertrophic cardiomyopathy.
@en
Electrophysiologic characteris ...... h hypertrophic cardiomyopathy.
@nl
type
label
Electrophysiologic characteris ...... h hypertrophic cardiomyopathy.
@en
Electrophysiologic characteris ...... h hypertrophic cardiomyopathy.
@nl
prefLabel
Electrophysiologic characteris ...... h hypertrophic cardiomyopathy.
@en
Electrophysiologic characteris ...... h hypertrophic cardiomyopathy.
@nl
P2093
P2860
P356
P1476
Electrophysiologic characteris ...... h hypertrophic cardiomyopathy.
@en
P2093
Frederic Joyce
Hector Barajas-Martínez
Robert J Goodrow
P2860
P304
P356
10.1111/PACE.12227
P577
2013-10-01T00:00:00Z